Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre.
Goodin
D S
DS
D000046:Academic Medical Centers / Q000592:standards / Q000706:statistics & numerical data; D002986:Clinical Trials as Topic / Q000592:standards*; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D015203:Reproducibility of Results; D055502:Secondary Prevention; D015983:Selection Bias; D013995:Time; D013997:Time Factors
D016899:Interferon-beta